Answer
Zytiga with prednisone/prednisolone treats adult men with newly diagnosed high-risk metastatic hormone-sensitive prostate cancer alongside ADT, or metastatic castration-resistant prostate cancer that is asymptomatic/mildly symptomatic after ADT failure when chemotherapy is not yet clinically indicated, or has progressed on/after docetaxel-based chemotherapy.
Sources for this answer
- ZYTIGA 500 mg film-coated tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.1 Therapeutic Indications · Version 12Document updated
Sources checked